chr17-16422739-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016113.5(TRPV2):c.475G>A(p.Asp159Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000147 in 1,591,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016113.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152250Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000906 AC: 19AN: 209802Hom.: 0 AF XY: 0.0000885 AC XY: 10AN XY: 112936
GnomAD4 exome AF: 0.000151 AC: 218AN: 1439338Hom.: 0 Cov.: 36 AF XY: 0.000140 AC XY: 100AN XY: 714168
GnomAD4 genome AF: 0.000105 AC: 16AN: 152250Hom.: 0 Cov.: 34 AF XY: 0.0000807 AC XY: 6AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.475G>A (p.D159N) alteration is located in exon 4 (coding exon 3) of the TRPV2 gene. This alteration results from a G to A substitution at nucleotide position 475, causing the aspartic acid (D) at amino acid position 159 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at